Suppr超能文献

骨骼中的芳香化酶:维生素D3和雄激素的作用。

Aromatase in bone: roles of Vitamin D3 and androgens.

作者信息

Yanase Toshihiko, Suzuki Shizu, Goto Kiminobu, Nomura Masatoshi, Okabe Taijiro, Takayanagi Ryoichi, Nawata Hajime

机构信息

Department of Medicine and Bioregulatory Science, Graduate School of Medical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka 812-8582, Japan.

出版信息

J Steroid Biochem Mol Biol. 2003 Sep;86(3-5):393-7. doi: 10.1016/s0960-0760(03)00349-2.

Abstract

We have mainly focused on the regulatory mechanism of cytochrome P450 aromatize in bone cells. Our previous study demonstrated a strong positive correlation of serum dehydroepiandrosterone sulfate (DHEA-S) and estrone (E1) with BMD in postmenopausal women but no correlation between serum estradiol (E2) and BMD in the same group. In addition, administration of DHEA to ovariectomized rat significantly increased BMD. These in vivo findings strongly suggested that circulating adrenal androgen may be converted to estrogen in osteoblast and may contribute to BMD maintenance. Actually, in cultured human osteoblast cells, DHEA was found to convert to androstenedione by 3beta-hydroxysteroid dehydrogenase (3beta-HSD) activity and then androstenedione to estrone through the apparent aromatase activity. The aromatase activity in cultured human osteoblast cells was significantly increased by dexamethasone (DEX). Interestingly, DEX and 1alpha,25-dihydroxyvitamin D3 (VD3) synergistically enhanced aromatase activity as well as P450arom mRNA expression. A little stronger induction of aromatase activity by DEX and VD3 was observed in cultured human fibroblasts. The increase of the aromatase activity by DEX and VD3 was accompanied with the increase of luciferase activity of fibroblast cells transfected with Exon 1b-promoter-luciferase construct, but not of osteoblasts transfected with the same construct, suggesting a different regulatory mechanism of aromatase by DEX and 1alpha,25-dihydroxyvitamin D3 (VD3) between these two cells despite the same promotor usage. In human bone cells, intracrine mechanism through aromatase activity, together with a positive regulation of aromatase activity by glucocorticoid and VD3, may contribute to the local production of estrogens, thus leading to protective effect against osteoporosis especially after menopause. The effect of sex steroids (estrogen versus testosterone) in bone remodeling was also briefly reviewed based on several recent findings in this field.

摘要

我们主要关注细胞色素P450芳香化酶在骨细胞中的调节机制。我们之前的研究表明,绝经后女性血清硫酸脱氢表雄酮(DHEA-S)和雌酮(E1)与骨密度呈强正相关,但同一组中血清雌二醇(E2)与骨密度无相关性。此外,给去卵巢大鼠注射DHEA可显著增加骨密度。这些体内研究结果强烈表明,循环中的肾上腺雄激素可能在成骨细胞中转化为雌激素,并可能有助于维持骨密度。实际上,在培养的人成骨细胞中,发现DHEA通过3β-羟基类固醇脱氢酶(3β-HSD)活性转化为雄烯二酮,然后通过明显的芳香化酶活性将雄烯二酮转化为雌酮。地塞米松(DEX)可显著增加培养的人成骨细胞中的芳香化酶活性。有趣的是,DEX和1α,25-二羟基维生素D3(VD3)协同增强芳香化酶活性以及P450arom mRNA表达。在培养的人成纤维细胞中观察到DEX和VD3对芳香化酶活性的诱导作用稍强。DEX和VD3导致的芳香化酶活性增加伴随着用外显子1b启动子-荧光素酶构建体转染的成纤维细胞荧光素酶活性的增加,但用相同构建体转染的成骨细胞则没有,这表明尽管使用相同的启动子,但这两种细胞中DEX和1α,25-二羟基维生素D3(VD3)对芳香化酶的调节机制不同。在人骨细胞中,通过芳香化酶活性的自分泌机制,以及糖皮质激素和VD3对芳香化酶活性的正向调节,可能有助于雌激素的局部产生,从而对骨质疏松症尤其是绝经后骨质疏松症产生保护作用。基于该领域最近的一些研究结果,还简要回顾了性类固醇(雌激素与睾酮)在骨重塑中的作用。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验